Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity

Experimental Cell Research

Volumn 317, Issue 2, 2011, Pages 195-209

  Albrechtsen, Reidar ^a   Stautz, Dorte ^a   Sanjay, Archana ^b   Kveiborg, Marie ^a   Wewer, Ulla M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADAM12; Ectodomain shedding; Invadopodia; Lipid rafts; Src; 3 integrin

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; BETA3 INTEGRIN; CAVEOLIN 1; CHOLESTEROL; DISINTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE; MONOCLONAL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CARCINOMA CELL; CATALYSIS; CELL ADHESION; CELL MEMBRANE; CELL STRAIN HEK293; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INVADOPODIA; LIPID RAFT; ONCOGENE SRC; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 78649460442     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.10.003     Document Type: Article

References (56)

1. Marchisio P.C., Cirillo D., Naldini L., Primavera M.V., Teti A., Zambonin-Zallone A. Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J. Cell Biol. 1984, 99:1696-1705.
2. Kelly T., Mueller S.C., Yeh Y., Chen W.T. Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell. Physiol. 1994, 158:299-308.
3. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007, 17:107-117.
4. Buccione R., Caldieri G., Ayala I. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 2009, 28:137-149.
5. Gimona M., Buccione R., Courtneidge S.A., Linder S. Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol. 2008, 20:235-241.
6. Spinardi L., Marchisio P.C. Podosomes as smart regulators of cellular adhesion. Eur. J. Cell Biol. 2006, 85:191-194.
7. Buccione R., Orth J.D., McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 2004, 5:647-657.
8. Ayala I., Baldassarre M., Giacchetti G., Caldieri G., Tete S., Luini A., Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J. Cell Sci. 2008, 121:369-378.
9. Mueller S.C., Yeh Y., Chen W.T. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol. 1992, 119:1309-1325.
10. Nakahara H., Mueller S.C., Nomizu M., Yamada Y., Yeh Y., Chen W.T. Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J. Biol. Chem. 1998, 273:9-12.
11. Mueller S.C., Ghersi G., Akiyama S.K., Sang Q.X., Howard L., Pineiro-Sanchez M., Nakahara H., Yeh Y., Chen W.T. A novel protease-docking function of integrin at invadopodia. J. Biol. Chem. 1999, 274:24947-24952.
12. Pfaff M., Jurdic P. Podosomes in osteoclast-like cells: structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin alphaVbeta3. J. Cell Sci. 2001, 114:2775-2786.
13. Linder S., Hufner K., Wintergerst U., Aepfelbacher M. Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J. Cell Sci. 2000, 113(Pt 23):4165-4176.
14. Chen W.T. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 1996, 49:59-71.
15. Nakahara H., Howard L., Thompson E.W., Sato H., Seiki M., Yeh Y., Chen W.T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7959-7964.
16. Abram C.L., Seals D.F., Pass I., Salinsky D., Maurer L., Roth T.M., Courtneidge S.A. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J. Biol. Chem. 2003, 278:16844-16851.
17. Poincloux R., Lizarraga F., Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 2009, 122:3015-3024.
18. Steffen A., Le Dez G., Poincloux R., Recchi C., Nassoy P., Rottner K., Galli T., Chavrier P. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr. Biol. 2008, 18:926-931.
19. Kveiborg M., Albrechtsen R., Couchman J.R., Wewer U.M. Cellular roles of ADAM12 in health and disease. Int. J. Biochem. Cell Biol. 2008, 40:1685-1702.
20. Frohlich C., Albrechtsen R., Dyrskjot L., Rudkjaer L., Orntoft T.F., Wewer U.M. Molecular profiling of ADAM12 in human bladder cancer. Clin. Cancer Res. 2006, 12:7359-7368.
21. Pories S.E., Zurakowski D., Roy R., Lamb C.C., Raza S., Exarhopoulos A., Scheib R.G., Schumer S., Lenahan C., Borges V., Louis G.W., Anand A., Isakovich N., Hirshfield-Bartek J., Wewer U., Lotz M.M., Moses M.A. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1034-1042.
22. Peduto L., Reuter V.E., Sehara-Fujisawa A., Shaffer D.R., Scher H.I., Blobel C.P. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 2006, 25:5462-5466.
23. Kveiborg M., Frohlich C., Albrechtsen R., Tischler V., Dietrich N., Holck P., Kronqvist P., Rank F., Mercurio A.M., Wewer U.M. A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res. 2005, 65:4754-4761.
24. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8:35-40.
25. Horiuchi K., Le Gall S., Schulte M., Yamaguchi T., Reiss K., Murphy G., Toyama Y., Hartmann D., Saftig P., Blobel C.P. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 2007, 18:176-188.
26. Kurisaki T., Masuda A., Sudo K., Sakagami J., Higashiyama S., Matsuda Y., Nagabukuro A., Tsuji A., Nabeshima Y., Asano M., Iwakura Y., Sehara-Fujisawa A. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell. Biol. 2003, 23:55-61.
27. Yamaguchi H., Lorenz M., Kempiak S., Sarmiento C., Coniglio S., Symons M., Segall J., Eddy R., Miki H., Takenawa T., Condeelis J. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 2005, 168:441-452.
28. Blouw B., Seals D.F., Pass I., Diaz B., Courtneidge S.A. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur. J. Cell Biol. 2008, 87:555-567.
29. Seals D.F., Azucena E.F., Pass I., Tesfay L., Gordon R., Woodrow M., Resau J.H., Courtneidge S.A. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005, 7:155-165.
30. Stautz D., Sanjay A., Hansen M.T., Albrechtsen R., Wewer U.M., Kveiborg M. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity. Exp. Cell Res. 2010, 316:55-67.
31. Kawaguchi N., Sundberg C., Kveiborg M., Moghadaszadeh B., Asmar M., Dietrich N., Thodeti C.K., Nielsen F.C., Moller P., Mercurio A.M., Albrechtsen R., Wewer U.M. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J. Cell Sci. 2003, 116:3893-3904.
32. Sanjay A., Houghton A., Neff L., DiDomenico E., Bardelay C., Antoine E., Levy J., Gailit J., Bowtell D., Horne W.C., Baron R. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 2001, 152:181-195.
33. Lydolph M.C., Morgan-Fisher M., Hoye A.M., Couchman J.R., Wewer U.M., Yoneda A. Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp. Cell Res. 2009, 315:3312-3324.
34. Playford M.P., Schaller M.D. The interplay between Src and integrins in normal and tumor biology. Oncogene 2004, 23:7928-7946.
35. Hsu A.R., Veeravagu A., Cai W., Hou L.C., Tse V., Chen X. Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment. Recent Pat. Anticancer Drug Discov. 2007, 2:143-158.
36. Chuntharapai A., Bodary S., Horton M., Kim K.J. Blocking monoclonal antibodies to alpha V beta 3 integrin: a unique epitope of alpha V beta 3 integrin is present on human osteoclasts. Exp. Cell Res. 1993, 205:345-352.
37. Bowden E.T., Coopman P.J., Mueller S.C. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Meth. Cell Biol. 2001, 63:613-627.
38. Moss M.L., Rasmussen F.H. Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening. Anal. Biochem. 2007, 366:144-148.
39. Caldieri G., Giacchetti G., Beznoussenko G., Attanasio F., Ayala I., Buccione R. Invadopodia biogenesis is regulated by caveolin-mediated modulation of membrane cholesterol levels. J. Cell. Mol. Med. 2009, 13:1728-1740.
40. Yamaguchi H., Takeo Y., Yoshida S., Kouchi Z., Nakamura Y., Fukami K. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res. 2009, 69:8594-8602.
41. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 2005, 6:32-43.
42. Kveiborg M., Jacobsen J., Lee M.H., Nagase H., Wewer U.M., Murphy G. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinases (TIMP)-2. Biochem. J. 2010, 430:79-86.
43. Thodeti C.K., Frohlich C., Nielsen C.K., Holck P., Sundberg C., Kveiborg M., Mahalingam Y., Albrechtsen R., Couchman J.R., Wewer U.M. Hierarchy of ADAM12 binding to integrins in tumor cells. Exp. Cell Res. 2005, 309:438-450.
44. Humphries M.J. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol. 1996, 8:632-640.
45. Chellaiah M.A. Regulation of podosomes by integrin alphavbeta3 and Rho GTPase-facilitated phosphoinositide signaling. Eur. J. Cell Biol. 2006, 85:311-317.
46. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., Strongin A.Y. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 2001, 263:209-223.
47. Chen W.T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 1989, 251:167-185.
48. Bowden E.T., Onikoyi E., Slack R., Myoui A., Yoneda T., Yamada K.M., Mueller S.C. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp. Cell Res. 2006, 312:1240-1253.
49. Cao Y., Kang Q., Zolkiewska A. Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1. Biochem. J. 2001, 357:353-361.
50. Orlichenko L., Weller S.G., Cao H., Krueger E.W., Awoniyi M., Beznoussenko G., Buccione R., McNiven M.A. Caveolae mediate growth factor-induced disassembly of adherens junctions to support tumor cell dissociation. Mol. Biol. Cell 2009, 20:4140-4152.
51. Caldieri G., Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol. 2010, 20:64-70.
52. Seals D.F., Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003, 17:7-30.
53. Kimura F., Iwaya K., Kawaguchi T., Kaise H., Yamada K., Mukai K., Matsubara O., Ikeda N., Kohno N. Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci. 2010, 101:1133-1140.
54. Carl-McGrath S., Lendeckel U., Ebert M., Roessner A., Rocken C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int. J. Oncol. 2005, 26:17-24.
55. Le Pabic H., Bonnier D., Wewer U.M., Coutand A., Musso O., Baffet G., Clement B., Theret N. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003, 37:1056-1066.
56. West M.A., Prescott A.R., Chan K.M., Zhou Z., Rose-John S., Scheller J., Watts C. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent. J. Cell Biol. 2008, 182:993-1005.